Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
Christer Baeck(Universitätsklinikum Aachen), Frank Tacke(Medizinische Hochschule Hannover), Christian Trautwein(Medizinische Hochschule Hannover), Alexander Wehr(Universitätsklinikum Aachen), Felix Heymann(Universitätsklinikum Aachen), Dirk Eulberg(Noxxon Pharma (Germany)), Sebastian Huss(University of Cologne), Mihael Vucur(Düsseldorf University Hospital), Karlin Raja Karlmark(Universitätsklinikum Aachen), Tom Luedde(Medizinische Hochschule Hannover), Sven Klußmann(Noxxon Pharma (Germany)), Nikolaus Gaßler(Jena University Hospital)
Cited by 608
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis
|Hepatology|2010|786